Facts about FCE (Fludarabine, Cytarabine, Etoposide) in Acute Myeloid Leukemia

Publisher： Karger

E-ISSN： 1421-9662|131|4|200-201

ISSN： 0001-5792

Source： Acta Haematologica, Vol.131, Iss.4, 2013-11, pp. : 200-201

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

The Combination of Fludarabine, Cytarabine and Etoposide Is an Active and Well-Tolerated Regimen in Relapsed/Refractory Acute Myeloid Leukemia

By  

Acta Haematologica, Vol. 131, Iss. 4, 2013-11 ,pp. : 202-207

Karger

Access to resources Recommend Favorite

A phase I study of lenalidomide plus chemotherapy with mitoxantrone, etoposide, and cytarabine for the reinduction of patients with acute myeloid leukemia

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 93, Iss. 2, 2018-02 ,pp. : 254-261

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cyclophosphamide/fludarabine nonmyeloablative allotransplant for acute myeloid leukemia

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 2, 2015-02 ,pp. : 97-99

John Wiley & Sons Inc

Access to resources Recommend Favorite

Fludarabine and Cytarabine Combination in the Induction of Adult Patients with Acute Myeloid Leukaemia

By  

Acta Haematologica, Vol. 137, Iss. 1, 2016-11 ,pp. : 15-16

Karger

Access to resources Recommend Favorite

Pilot Study of Gemtuzumab Ozogamicin (GO), Fludarabine, Cytarabine and Idarubicin Combined Regimen (GO-FLAI) as First-Line Induction Therapy plus GO Alone as Consolidation Therapy for Elderly Acute Myeloid Leukemia Patients

By  

Acta Haematologica, Vol. 118, Iss. 1, 2007-03 ,pp. : 7-9

Karger

Access to resources Recommend Favorite